🎁 Black Friday: up to 50% off of annual plans
Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.50
-0.90 (-3.17%)
Nov 20, 2026, 1:30 PM CST

TPEX:4111 Revenue

Chi Sheng Pharma & Biotech had revenue of 354.72M TWD in the quarter ending September 30, 2026, with 3.68% growth. This brings the company's total for the last twelve months to 1.43B, up 5.33% year-over-year. In the year 2025, Chi Sheng Pharma & Biotech had annual revenue of 1.38B with 18.11% growth. That makes Chi Sheng Pharma & Biotech the 28,999th largest company in the world by revenue and 1,395th in Taiwan.

Revenue (ttm)
1.43B
Revenue Growth
+5.33%
P/S Ratio
1.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.65B

Revenue Chart

Revenue by Geography

  • Taiwan 1.15B 98.9%
  • Others 12.33M 1.1%
Fiscal year ended Dec 31, 2024 See the full TPEX:4111 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.38B211.04M18.11%
Dec 31, 20241.17B104.57M9.86%
Dec 31, 20231.06B-82.21M-7.19%
Dec 31, 20221.14B120.78M11.81%
Dec 31, 20211.02B42.94M4.38%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.